DeVry Inc. (NYSE: DV), Adeona Pharmaceuticals (NYSE: AEN), Celsion Co. (NASDAQ: CLSN), Costar Group Inc (NASDAQ: CSGP) and Health Care REIT (NYSE: HCN) getting new coverage from analysts.
Credit Suisse (NYSE:CS) initiated coverage on DeVry Inc. (DV). They placed a “Neutral” rating and a price target of $36.00 on the company.
Chardan Capital Markets initiated coverage on Adeona Pharmaceuticals (AEN). They placed a “Buy” rating and a price target of $1.00 on the company.
Rodman & Renshaw initiated coverage on Celsion Co. (CLSN). They placed an “Outperform” rating and a price target of $6.00 on the company.
Needham & Company initiated coverage on Costar Group Inc. (CSGP). They placed a “Buy” rating and a price target of $70.00 on the company.
Barclays Capital initiated coverage on Health Care REIT (HCN). They placed an “Overweight” rating on the company.
No comments:
Post a Comment